Medical Health & Life Science Research News

Detailed examination of the liver failure pipeline for drug profile and companies in H1 2017 report

Detailed examination of the liver failure pipeline for drug profile and companies in H1 2017 report

The Liver Failure pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- Agency -.

The Liver Failure Pipeline guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Liver Failure Pipeline - Drug Profiles : Antisense RNAi Oligonucleotide to Inhibit FAS for Liver Diseases, BL-1220, Cell Therapy for Acute Liver Failure and Alcoholic Hepatitis, Cell Therapy for Liver Failure, emricasan, F-573, HepaStem, ImmuneSafe, MTL-CEBPA, Oligonucleotide for Liver Failure, ornithine phenylacetate, PP-100, Recombinant Protein to Inhibit JNK for Liver Failure, VEN-100, XEN-103.

Access Complete Report On Liver Failure Pipeline Review H1 2017: www.reportsnreports.com/purchase.aspx?name=1057936

Key players of Liver Failure Pipeline Alfact Innovation,BioLineRx Ltd,Cell2B Advanced Therapeutics SA,Conatus Pharmaceuticals Inc,Immune Pharmaceuticals Inc,Mina Therapeutics Ltd,Mylan NV,Ocera Therapeutics Inc,PledPharma AB,Promethera Biosciences SA,Silence Therapeutics Plc,Unicyte AG,Ventria Bioscience,Vital Therapies Inc

Get Liver Failure Pipeline Review Report [email protected] www.reportsnreports.com/contacts/d…aspx?name=1057936

The Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Failure and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 3 and 1 respectively.

- Agency -.

Scope

The report provides a snapshot of the global therapeutic landscape of Liver Failure. The report reviews pipeline therapeutics for Liver Failure by companies and universities/research institutes based on information derived from company and industry-specific sources.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Liver Failure therapeutics and enlists all their major and minor projects. The report assesses Liver Failure therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Liver Failure

Liver Failure pipeline (Oncology) guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

List of Figures
Number of Products under Development for Liver Failure, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.